DSM Invests in Sciona

DSM Invests in Sciona

HEERLEN, The NetherlandsDSMVenturing (www.dsmventuring.com), part of the DSM Venturing and Business Developmentbusiness group, invested in Sciona Inc., a New Haven, Conn.-based companyfocused on nutrigenomics. The lead product from Sciona (www.sciona.com) isNutritionScreen, a genetic testing method to provide individuals withnutritional advice based on their genetic profile and lifestyle.

The human nutrition market sees a demand increase driven byhealth awareness, preventive treatment and the aging population, said JanZuidam, vice chairman of DSMs managing board. New products, services andtechnologies are important to an innovative company like DSM. The field ofnutrigenomics fits perfectly with our ambition in the field of life sciencesinnovation.